C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/31 (2006.01) A61K 39/09 (2006.01) C07K 14/315 (2006.01) C07K 16/12 (2006.01) C12N 15/62 (2006.01) G01N 33/53 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2475821
The present invention relates to polypeptides, epitopes and antibodies directed to these epitopes, more particularly to the Sip polypeptide of Group B streptococcus (GBS), also called Streptococcus Agalactiae which may be used to prevent, diagnose and/or treat streptococcal infection.
La présente invention concerne des polypeptides, des épitopes et des anticorps dirigés contre lesdits épitopes, et, plus particulièrement, le polypeptide Sip du streptocoque du groupe B (GBS), également désigné sous le nom de Streptococcus Agalactiae, et qui peut être utilisé pour prévenir, diagnostiquer et/ou traiter une infection à streptocoques.
Brodeur Bernard R.
Hamel Josee
Martin Denis
Rioux Stephane
Id Biomedical Corporation
Shire Biochem Inc.
Smart & Biggar
LandOfFree
Group b streptococcus antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Group b streptococcus antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Group b streptococcus antigens will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1729579